Moving away from ‘failed’ prednisone to IL-6 blockade in giant cell arteritis

Recent landmark study results have shown that interleukin-6 blockade may be superior to prolonged prednisone therapy in giant cell arteritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.“The great majority of patients with GCA are unsuccessful in tapering their prednisone,” John H. Stone, MD, director of clinical rheumatology at Massachusetts General

Read the full article here

Related Articles